Allscripts Reports Fourth Quarter Results

Allscripts Healthcare Solutions, Inc. (Allscripts) MDRX today announced its financial results for the three months ended December 31, 2010. Fourth Quarter Highlights: Fourth quarter total bookings of $288.2 million, including legacy Allscripts bookings of $140.4 million and legacy Eclipsys bookings of $147.8 million Total bookings growth of 34 percent sequentially over the third quarter of 2010 Legacy Eclipsys bookings growth of 31 percent in calendar 2010 GAAP revenue of $316.2 million; total non-GAAP revenue of $337.1 million, a 10 percent year-over-year increase GAAP operating income of $9.5 million; total non-GAAP operating income of $69.3 million, a 26 percent year-over-year increase GAAP net loss of $6.2 million and diluted net loss per share of $0.03; total non-GAAP net income of $38.7 million and non-GAAP diluted earnings per share of $0.20 Non-GAAP net income and earnings per share reflect adjustments to GAAP results, largely associated with the Eclipsys merger, all on a net-of-tax basis, consisting of: $12.7 million or $0.07 per share for an acquisition-related deferred revenue adjustment; $10.6 million or $0.05 per share for acquisition-related amortization expense; $2.3 million or $0.01 per share for stock-based compensation expense; and, $10.9 million, or $0.06 per share for transaction-related expenses; $8.4 million, or $0.04 per share of additional income tax expense primarily related to non-deductible merger-related expenses $74.3 million in cash flow from operations; reduced long-term debt by $40.9 million
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!